Eagle Pharmaceuticals (EGRX) Adopts Limited Duration Stockholder Rights Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
October 31, 2024 8:00 AM EDTWOODCLIFF LAKE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (the Company or Eagle) (OTCMKTS: EGRX) today announced that its Board of Directors (the Board) has adopted a limited duration stockholder rights agreement (the Rights Plan), effective immediately.
The Company continues to experience a significant dislocation in the trading price of its common stock. The Rights Plan is intended to enable each of the Companys stockholders to have the opportunity to realize the long-term value of their investment. The Rights Plan is intended to reduce the likelihood that any... More
